Cooper C. Collins's Net Worth

$25.3 Million

Estimate Recalculated Feb 7, 2024 03:57PM EST

Who is Cooper C. Collins?

Cooper C. Collins has an estimated net worth of $25.3 Million. This is based on reported shares across multiple companies, which include TherapeuticsMD, Inc., and PERNIX THERAPEUTICS HOLDINGS, INC..

SEC CIK

Cooper C. Collins's CIK is 0001485508

Past Insider Trading and Trends

2021 was Cooper C. Collins's most active year for acquiring shares with 5 total transactions. Cooper C. Collins's most active month to acquire stocks was the month of May. 2013 was Cooper C. Collins's most active year for disposing of shares, totalling 16 transactions. Cooper C. Collins's most active month to dispose stocks was the month of September. 2021 saw Cooper C. Collins paying a total of $1,303,500.00 for 2,196,038 shares, this is the most they've acquired in one year. In 2014 Cooper C. Collins cashed out on 3,860,000 shares for a total of $13,103,902.88, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TherapeuticsMD, Inc. (TXMD) Snapshot price: $2.33

Investor

Cooper C. Collins owns 46,722 units of Common Stock which is worth $108,862.26. From 2012 to 2023 Cooper C. Collins acquired a total of 2,238,848 shares in TherapeuticsMD, Inc. at a cost of $1,687,276.80, Cooper also disposed a total of 2,631,579 shares of TherapeuticsMD, Inc. equalling to $4,605,263.25.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 17
Form 4
—
0
—
—
0
Sep 29
Form 4
+4.43%
1.98K
—
—
46.72K
Aug 18
Form 4
+80.85%
1M
$0.58
$578,500.00
2.24M
Nov 18
Form 4
+422.18%
1M
$0.73
$725,000.00
1.24M
Aug 17 - Aug 18
Form 4
+69.19%
96.86K
—
—
236.86K
Aug 10
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jun 18
Form 4
+112.12%
74K
$1.45
$107,300.00
140K
Jun 8 - Jun 9
Form 4
—
0
—
—
0
Jun 20
Form 4
+83.33%
30K
$3.33
$99,870.00
66K
May 13
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Dec 21
Form 4
+80.00%
16K
$6.23
$99,716.80
36K
Mar 11
Form 4
—
0
—
—
0
Dec 17
Form 4
—
0
—
—
0
Mar 25
Form 4
∞
20K
$3.84
$76,890.00
20K
Jun 5
Form 4
—
0
—
—
0
Jan 6
Form 4
-100.00%
-2.63M
$1.75
-$4,605,263.25
0
Jun 14
Form 4
—
0
—
—
0
May 1
Form 4
—
0
—
—
0
Apr 16
Form 3
—
0
—
—
0
No matching records found

PERNIX THERAPEUTICS HOLDINGS, INC. No price found

Chief Strategic Officer

Cooper C. Collins owns 2,500,046 units of Common Stock. From 2010 to 2014 Cooper C. Collins acquired a total of 9,405,000 shares in PERNIX THERAPEUTICS HOLDINGS, INC., Cooper also disposed a total of 5,878,429 shares of PERNIX THERAPEUTICS HOLDINGS, INC. equalling to $22,265,815.08.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.47%
-90.00K
$5.26
-$473,083.45
2.5M
Scheduled
Apr 1 - Apr 2
Form 4
-58.09%
-3.59M
$3.40
-$12,223,769.84
2.59M
Scheduled
Mar 3 - Mar 4
Form 4
-1.44%
-90.00K
$2.22
-$199,724.37
6.18M
Scheduled
Feb 3 - Feb 5
Form 4
-0.44%
-27.96K
$2.20
-$61,611.47
6.27M
Scheduled
Jan 7
Form 4
-0.98%
-62.04K
$2.35
-$145,713.74
6.3M
Scheduled
Jan 2 - Jan 6
Form 4
-0.59%
-37.45K
$2.31
-$86,627.60
6.36M
Scheduled
Dec 5 - Dec 6
Form 4
-0.81%
-52.55K
$2.44
-$128,212.24
6.4M
Scheduled
Dec 2 - Dec 4
Form 4
-1.38%
-90.00K
$2.01
-$180,607.12
6.45M
Scheduled
Nov 1 - Nov 5
Form 4
-0.36%
-23.36K
$2.47
-$57,725.05
6.54M
Scheduled
Oct 4 - Oct 8
Form 4
-1.01%
-66.64K
$2.55
-$169,737.20
6.56M
Scheduled
Oct 1 - Oct 3
Form 4
-15.86%
-1.25M
$4.04
-$5,050,000.00
6.63M
Jul 24
Form 4
-5.30%
-498.43K
$7.00
-$3,489,003.00
8.91M
Jul 21
Form 4
∞
9.4M
—
—
9.4M
Mar 9
Form 3
—
0
—
—
0
No matching records found